| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.995 | 0.001 | 0.995 | Hypoxia-inducible factor 1 alpha inhibitor | 0.995 0.001 DBMET02589 0.993 0.001 DBMET02590 0.993 0.001 DBMET02591 | ||
| 0.993 | 0.001 | 0.993 | Antipruritic | 0.993 0.001 DBMET02589 0.987 0.001 DBMET02590 0.978 0.001 DBMET02591 | ||
| 0.992 | 0.003 | 0.995 | Antiinflammatory | 0.992 0.003 DBMET02589 0.992 0.003 DBMET02590 0.995 0.003 DBMET02591 | DBMET02591 | |
| 0.962 | 0.004 | 0.972 | Toll-Like receptor agonist | 0.966 0.004 DBMET02589 0.96 0.004 DBMET02590 0.972 0.003 DBMET02591 | DBMET02591 | |
| 0.961 | 0.004 | 0.972 | Toll-Like receptor 7 agonist | 0.965 0.004 DBMET02589 0.959 0.004 DBMET02590 0.972 0.003 DBMET02591 | DBMET02591 | |
| 0.933 | 0.004 | 0.948 | Transcription factor NF kappa B inhibitor | 0.943 0.003 DBMET02589 0.947 0.003 DBMET02590 0.948 0.003 DBMET02591 | DBMET02591 | |
| 0.91 | 0 | 0.927 | Lipocortins synthesis agonist | 0.913 0 DBMET02589 0.877 0 DBMET02590 0.927 0 DBMET02591 | DBMET02591 | |
| 0.896 | 0 | 0.896 | Arachidonic acid antagonist | 0.875 0 DBMET02589 0.865 0 DBMET02590 0.721 0 DBMET02591 | ||
| 0.86 | 0 | 0.953 | Corticosteroid-like | 0.875 0 DBMET02589 0.836 0 DBMET02590 0.953 0 DBMET02591 | DBMET02591 | |
| 0.857 | 0 | 0.919 | Glucocorticoid agonist | 0.867 0 DBMET02589 0.862 0 DBMET02590 0.919 0 DBMET02591 | DBMET02591 | |
| 0.839 | 0.003 | 0.853 | Immunosuppressant | 0.843 0.003 DBMET02589 0.836 0.003 DBMET02590 0.853 0.003 DBMET02591 | DBMET02591 | |
| 0.759 | 0.001 | 0.875 | Androgen agonist | 0.875 0.001 DBMET02589 0.565 0.002 DBMET02590 0.696 0.001 DBMET02591 | DBMET02589 | |
| 0.73 | 0.003 | 0.873 | Androgen antagonist | 0.873 0.002 DBMET02589 0.688 0.003 DBMET02590 0.854 0.002 DBMET02591 | DBMET02589 | |
| 0.649 | 0.002 | 0.851 | Glucocorticoid antagonist | 0.709 0.001 DBMET02589 0.655 0.002 DBMET02590 0.851 0.001 DBMET02591 | DBMET02591 | |
| 0.505 | 0.003 | 0.566 | Aromatase inhibitor | 0.566 0.003 DBMET02589 0.459 0.004 DBMET02590 0.55 0.003 DBMET02591 | DBMET02589 | |
| 0.501 | 0.004 | 0.509 | Lipocortins synthesis antagonist | 0.505 0.004 DBMET02589 0.488 0.004 DBMET02590 0.509 0.004 DBMET02591 | DBMET02591 | |
| 0.497 | 0.006 | 0.578 | Interferon gamma antagonist | 0.53 0.005 DBMET02589 0.545 0.004 DBMET02590 0.578 0.003 DBMET02591 | DBMET02591 | |
| 0.504 | 0.073 | 0.521 | Apoptosis agonist | 0.521 0.068 DBMET02589 0.495 0.076 DBMET02590 0.517 0.069 DBMET02591 | DBMET02589 | |
| 0.399 | 0.003 | 0.531 | Progesterone antagonist | 0.521 0.002 DBMET02589 0.385 0.003 DBMET02590 0.531 0.002 DBMET02591 | DBMET02591 | |
| 0.37 | 0.029 | 0.393 | Sodium/bile acid cotransporter inhibitor | 0.384 0.022 DBMET02589 0.383 0.023 DBMET02590 0.393 0.019 DBMET02591 | DBMET02591 | |
| 0.358 | 0.029 | 0.451 | DNA synthesis inhibitor | 0.379 0.025 DBMET02589 0.397 0.022 DBMET02590 0.451 0.017 DBMET02591 | DBMET02591 | |
| 0.326 | 0.014 | 0.634 | NOS3 expression enhancer | 0.4 0.008 DBMET02589 0.459 0.006 DBMET02590 0.634 0.004 DBMET02591 | DBMET02591 | |
| 0.3 | 0.009 | 0.46 | Interleukin 4 antagonist | 0.337 0.006 DBMET02589 0.406 0.005 DBMET02590 0.46 0.005 DBMET02591 | DBMET02591 | |
| 0.272 | 0.004 | 0.272 | 5-Alpha-reductase inhibitor | 0.251 0.004 DBMET02589 0.188 0.005 DBMET02590 0.142 0.007 DBMET02591 | ||
| 0.276 | 0.037 | 0.276 | Hepatoprotectant | 0.263 0.04 DBMET02589 0.254 0.042 DBMET02590 0.231 0.05 DBMET02591 | ||
| 0.282 | 0.044 | 0.328 | Nitric oxide antagonist | 0.305 0.039 DBMET02589 0.28 0.044 DBMET02590 0.328 0.035 DBMET02591 | DBMET02591 | |
| 0.264 | 0.037 | 0.339 | P-glycoprotein inhibitor | 0.29 0.031 DBMET02589 0.298 0.029 DBMET02590 0.339 0.023 DBMET02591 | DBMET02591 | |
| 0.252 | 0.026 | 0.252 | Lipid peroxidase inhibitor | 0.233 0.031 DBMET02589 0.247 0.027 DBMET02590 0.245 0.028 DBMET02591 | ||
| 0.228 | 0.002 | 0.239 | Anabolic | 0.239 0.002 DBMET02589 0.221 0.003 DBMET02590 0.214 0.003 DBMET02591 | DBMET02589 | |
| 0.302 | 0.084 | 0.323 | Apoptosis antagonist | 0.323 0.071 DBMET02589 0.28 0.1 DBMET02590 0.28 0.1 DBMET02591 | DBMET02589 | |
| 0.304 | 0.089 | 0.308 | Cholesterol antagonist | 0.284 0.102 DBMET02589 0.308 0.086 DBMET02590 0.242 0.131 DBMET02591 | DBMET02590 | |
| 0.24 | 0.055 | 0.257 | Anesthetic general | 0.236 0.057 DBMET02589 0.257 0.047 DBMET02590 0.227 0.061 DBMET02591 | DBMET02590 | |
| 0.187 | 0.006 | 0.332 | Interleukin 5 antagonist | 0.226 0.005 DBMET02589 0.249 0.005 DBMET02590 0.332 0.004 DBMET02591 | DBMET02591 | |
| 0.257 | 0.08 | 0.281 | Antioxidant | 0.255 0.081 DBMET02589 0.281 0.069 DBMET02590 0.276 0.071 DBMET02591 | DBMET02590 | |
| 0.177 | 0.009 | 0.177 | Estrogen agonist | 0.174 0.009 DBMET02589 0.164 0.01 DBMET02590 0.17 0.01 DBMET02591 | ||
| 0.192 | 0.046 | 0.253 | Interleukin 6 antagonist | 0.239 0.025 DBMET02589 0.208 0.036 DBMET02590 0.253 0.023 DBMET02591 | DBMET02591 | |
| 0.254 | 0.114 | 0.285 | Interleukin 2 agonist | 0.285 0.085 DBMET02589 0.262 0.106 DBMET02590 0.281 0.088 DBMET02591 | DBMET02589 | |
| 0.142 | 0.003 | 0.142 | Nitric oxide donor | 0.138 0.003 DBMET02589 0.14 0.003 DBMET02590 0.14 0.003 DBMET02591 | ||
| 0.159 | 0.02 | 0.203 | Estrogen antagonist | 0.169 0.018 DBMET02589 0.168 0.018 DBMET02590 0.203 0.013 DBMET02591 | DBMET02591 | |
| 0.183 | 0.048 | 0.183 | Protein kinase stimulant | 0.142 0.074 DBMET02589 0.14 0.075 DBMET02590 | ||
| 0.147 | 0.032 | 0.208 | Antineoplastic antibiotic | 0.186 0.023 DBMET02589 0.157 0.029 DBMET02590 0.208 0.02 DBMET02591 | DBMET02591 | |
| 0.137 | 0.031 | 0.176 | Antineoplastic alkaloid | 0.128 0.035 DBMET02589 0.174 0.021 DBMET02590 0.176 0.02 DBMET02591 | DBMET02591 | |
| 0.149 | 0.045 | 0.179 | Cholesterol synthesis inhibitor | 0.179 0.032 DBMET02589 0.154 0.042 DBMET02590 0.166 0.037 DBMET02591 | DBMET02589 | |
| 0.097 | 0.004 | 0.108 | Progesterone agonist | 0.108 0.003 DBMET02589 0.066 0.004 DBMET02590 0.094 0.004 DBMET02591 | DBMET02589 | |
| 0.142 | 0.062 | 0.154 | Farnesoid X receptor antagonist | 0.137 0.069 DBMET02589 0.154 0.048 DBMET02590 0.15 0.052 DBMET02591 | DBMET02590 | |
| 0.128 | 0.052 | 0.138 | Microtubule formation inhibitor | 0.123 0.057 DBMET02589 0.138 0.044 DBMET02590 0.114 0.068 DBMET02591 | DBMET02590 | |
| 0.08 | 0.008 | 0.107 | RNA-directed RNA polymerase stimulant | 0.08 0.008 DBMET02589 0.09 0.007 DBMET02590 0.107 0.006 DBMET02591 | DBMET02591 | |
| 0.1 | 0.031 | 0.118 | Na+ K+ transporting ATPase inhibitor | 0.108 0.025 DBMET02589 0.106 0.027 DBMET02590 0.118 0.017 DBMET02591 | DBMET02591 | |
| 0.097 | 0.035 | 0.11 | Glycine receptor antagonist | 0.106 0.027 DBMET02589 0.102 0.03 DBMET02590 0.11 0.024 DBMET02591 | DBMET02591 | |
| 0.117 | 0.057 | 0.146 | Topoisomerase I inhibitor | 0.146 0.043 DBMET02589 | DBMET02589 | |
| 0.072 | 0.014 | 0.129 | Mineralocorticoid receptor antagonist | 0.092 0.009 DBMET02589 0.085 0.01 DBMET02590 0.129 0.005 DBMET02591 | DBMET02591 | |
| 0.143 | 0.091 | 0.155 | Melanin inhibitor | 0.143 0.092 DBMET02589 0.155 0.076 DBMET02590 0.153 0.077 DBMET02591 | DBMET02590 | |
| 0.086 | 0.046 | 0.155 | T cell inhibitor | 0.093 0.032 DBMET02589 0.112 0.017 DBMET02590 0.155 0.009 DBMET02591 | DBMET02591 | |
| 0.1 | 0.064 | 0.11 | Estrogen receptor beta antagonist | 0.1 0.064 DBMET02589 0.103 0.058 DBMET02590 0.11 0.046 DBMET02591 | DBMET02591 | |
| 0.11 | 0.076 | 0.247 | Topoisomerase II inhibitor | 0.201 0.033 DBMET02589 0.119 0.067 DBMET02590 0.247 0.025 DBMET02591 | DBMET02591 | |
| 0.055 | 0.021 | 0.055 | Microtubule stabilization | 0.052 0.025 DBMET02589 0.055 0.021 DBMET02590 0.049 0.029 DBMET02591 | ||
| 0.047 | 0.014 | 0.079 | Glucose-6-phosphate dehydrogenase inhibitor | 0.067 0.005 DBMET02589 0.05 0.012 DBMET02590 0.079 0.004 DBMET02591 | DBMET02591 | |
| 0.041 | 0.008 | 0.042 | 5-Alpha-reductase 2 inhibitor | 0.042 0.008 DBMET02589 0.029 0.009 DBMET02590 0.022 0.011 DBMET02591 | DBMET02589 | |
| 0.154 | 0.12 | 0.173 | Angiogenesis stimulant | 0.173 0.109 DBMET02589 0.147 0.124 DBMET02590 0.148 0.124 DBMET02591 | DBMET02589 | |
| 0.1 | 0.069 | 0.105 | Toll-Like receptor 4 antagonist | 0.105 0.062 DBMET02589 | DBMET02589 | |
| 0.107 | 0.079 | 0.132 | DNA polymerase I inhibitor | 0.1 0.086 DBMET02589 0.132 0.06 DBMET02590 0.106 0.08 DBMET02591 | DBMET02590 | |
| 0.032 | 0.008 | 0.034 | 5-Alpha-reductase 1 inhibitor | 0.034 0.008 DBMET02589 0.023 0.01 DBMET02590 0.019 0.011 DBMET02591 | DBMET02589 | |
| 0.132 | 0.11 | 0.151 | Ca2+-transporting ATPase inhibitor | 0.151 0.04 DBMET02589 0.139 0.076 DBMET02591 | DBMET02589 | |
| 0.083 | 0.064 | 0.088 | Transcription factor NF kappa B stimulant | 0.078 0.075 DBMET02589 0.088 0.053 DBMET02590 0.082 0.065 DBMET02591 | DBMET02590 | |
| 0.018 | 0.001 | 0.137 | Transcortin receptor antagonist | 0.024 0.001 DBMET02589 0.028 0.001 DBMET02590 0.137 0 DBMET02591 | DBMET02591 | |
| 0.036 | 0.023 | 0.066 | Estrogen receptor alpha agonist | 0.033 0.024 DBMET02589 0.049 0.018 DBMET02590 0.066 0.014 DBMET02591 | DBMET02591 | |
| 0.15 | 0.138 | 0.198 | Neurotrophic factor enhancer | 0.152 0.135 DBMET02589 0.198 0.078 DBMET02590 0.198 0.079 DBMET02591 | DBMET02591 | |
| 0.051 | 0.039 | 0.054 | Protein 50S ribosomal subunit inhibitor | 0.054 0.035 DBMET02589 | DBMET02589 | |
| 0.07 | 0.062 | 0.196 | Topoisomerase II alpha inhibitor | 0.156 0.022 DBMET02589 0.085 0.05 DBMET02590 0.196 0.015 DBMET02591 | DBMET02591 | |
| 0.122 | 0.118 | 0.142 | Growth hormone agonist | 0.142 0.094 DBMET02589 0.128 0.11 DBMET02590 | DBMET02589 | |
| 0.058 | 0.054 | 0.064 | Heme oxygenase stimulant | 0.059 0.05 DBMET02589 0.059 0.05 DBMET02590 0.064 0.036 DBMET02591 | DBMET02591 | |
| 0.043 | 0.041 | 0.197 | Aldosterone antagonist | 0.083 0.01 DBMET02589 0.065 0.017 DBMET02590 0.197 0.004 DBMET02591 | DBMET02591 | |
| 0.011 | 0.012 | 0.012 | 3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor | 0.012 0.008 DBMET02591 | DBMET02591 | |
| 0.017 | 0.022 | 0.03 | Estrone sulfatase inhibitor | 0.02 0.017 DBMET02589 0.02 0.017 DBMET02590 0.03 0.01 DBMET02591 | DBMET02591 | |
| 0.021 | 0.027 | 0.038 | Estrogen receptor beta agonist | 0.038 0.022 DBMET02591 | DBMET02591 | |
| 0.195 | 0.226 | 0.36 | Alpha-glucosidase inhibitor | 0.36 0.131 DBMET02590 0.324 0.148 DBMET02591 | DBMET02590 | |
| 0.062 | 0.097 | 0.08 | Estrogen receptor alpha antagonist | 0.08 0.049 DBMET02591 | DBMET02591 | |
| 0.132 | 0.173 | 0.156 | Immunostimulant | 0.156 0.15 DBMET02589 | DBMET02589 | |
| 0.071 | 0.113 | 0.096 | Expectorant | 0.096 0.073 DBMET02589 | DBMET02589 | |
| 0.073 | 0.12 | 0.093 | Adenylate cyclase inhibitor | 0.093 0.091 DBMET02590 | DBMET02590 | |
| 0.075 | 0.166 | 0.137 | Thrombolytic | 0.137 0.093 DBMET02590 0.119 0.111 DBMET02591 | DBMET02590 | |
| 0.075 | 0.184 | 0.172 | Interleukin 8 antagonist | 0.145 0.037 DBMET02590 0.172 0.022 DBMET02591 | DBMET02591 | |
| 0.051 | 0.173 | 0.127 | DNA intercalator | 0.119 0.058 DBMET02589 0.127 0.053 DBMET02591 | DBMET02591 | |
| 0.148 | 0.28 | 0.193 | Caspase 3 stimulant | 0.193 0.181 DBMET02589 0.193 0.18 DBMET02591 | DBMET02591 | |
| 0.086 | 0.239 | 0.226 | Aldehyde oxidase inhibitor | 0.226 0.092 DBMET02591 | DBMET02591 | |
| 0.021 | 0.198 | 0.05 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.05 0.043 DBMET02591 | DBMET02591 | |
| 0.114 | 0.339 | 0.171 | Peptidyltransferase inhibitor | 0.171 0.145 DBMET02591 | DBMET02591 | |
| 0.059 | 0.311 | 0.199 | Interleukin antagonist | 0.134 0.131 DBMET02590 0.199 0.085 DBMET02591 | DBMET02591 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |